ANTIEMETIC PROPERTIES OF THE 5HT3-RECEPTOR ANTAGONIST, GR38032F

被引：141

作者：

STABLES, R

ANDREWS, PLR

BAILEY, HE

COSTALL, B

GUNNING, SJ

HAWTHORN, J

NAYLOR, RJ

TYERS, MB

机构：

[1] ST GEORGES HOSP,SCH MED,LONDON,ENGLAND

[2] UNIV BRADFORD,POSTGRAD SCH STUDIES PHARMACOL,BRADFORD BD7 1DP,W YORKSHIRE,ENGLAND

来源：

CANCER TREATMENT REVIEWS | 1987年 / 14卷 / 3-4期

关键词：

D O I：

10.1016/0305-7372(87)90026-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：333 / 336

页数：4

共 9 条

[1]

ANDREWS P L R, 1987, British Journal of Pharmacology, V91, p417P

[2]

ANDREWS PLR, 1986, J PHYSIOL-LONDON, V378, pP16

[3]

ANDREWS PLR, 1987, J PHYSIOL-LONDON, V382, pP47

[4] PROPOSALS FOR THE CLASSIFICATION AND NOMENCLATURE OF FUNCTIONAL RECEPTORS FOR 5-HYDROXYTRYPTAMINE [J].

BRADLEY, PB ;

ENGEL, G ;

FENIUK, W ;

FOZARD, JR ;

HUMPHREY, PPA ;

MIDDLEMISS, DN ;

MYLECHARANE, EJ ;

RICHARDSON, BP ;

SAXENA, PR .

NEUROPHARMACOLOGY, 1986, 25 (06) :563-576

[5]

BRITTAIN R T, 1987, British Journal of Pharmacology, V90, p87P

[6]

COSTALL B, 1987, British Journal of Pharmacology, V90, p90P

[7] PREVENTION OF EMESIS IN PATIENTS RECEIVING CYTOTOXIC DRUGS BY GR38032F, A SELECTIVE 5-HT3 RECEPTOR ANTAGONIST [J].

CUNNINGHAM, D ;

POPLE, A ;

FORD, HT ;

HAWTHORN, J ;

GAZET, JC ;

CHALLONER, T ;

COOMBES, RC .

LANCET, 1987, 1 (8548) :1461-1463

[8]

Miner W., 1986, BR J PHARM P S, V88, P374

[9] INHIBITION OF CISPLATIN-INDUCED VOMITING BY SELECTIVE 5-HYDROXYTRYPTAMINE M-RECEPTOR ANTAGONISM [J].

MINER, WD ;

SANGER, GJ .

BRITISH JOURNAL OF PHARMACOLOGY, 1986, 88 (03) :497-499

← 1 →